Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2012
06/14/2012CA2816406A1 Hydroxylated aminotriazole derivatives as alx receptor agonists
06/14/2012CA2816376A1 Oxazolyl-methylether derivatives as alx receptor agonists
06/13/2012EP2463283A1 Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
06/13/2012EP2463282A1 4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
06/13/2012EP2463279A1 Amide derivative
06/13/2012EP2463278A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462139A1 Sphingosine-1-phosphate receptor agonists
06/13/2012EP2462138A1 Antiviral compounds and methods of making and using there of cross reference to related applications
06/13/2012EP2462135A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors
06/13/2012EP2462128A2 Compounds as lysophosphatidic acid receptor antagonists
06/13/2012EP2462123A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
06/13/2012EP2461688A1 Pesticidal compositions
06/13/2012EP1973546B1 Cholesteryl ester transfer protein inhibitors
06/13/2012EP1836180B1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
06/13/2012EP1781635B1 Potassium channel inhibitors
06/13/2012EP1704145B1 Selective kinase inhibitors
06/13/2012CN102498107A Heteroaryl compounds as kinase inhibitors
06/13/2012CN102498103A Pyrazine carboxamides as inhibitors of DGAT1
06/13/2012CN102498097A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498096A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497866A Oxazolidinone containing dimer compounds, compositions and methods to make and use
06/13/2012CN102491973A Synthetic method for ZD (Zero Defects)-4054
06/13/2012CN102491969A Heteroaromatic quinoline compounds
06/13/2012CN101914095B 2-chloropyridine derivative, preparation method and application thereof to preparation of medicines resistant to liver cancer
06/13/2012CN101646650B Sub-type selective azabicycloalkane derivatives
06/13/2012CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof
06/13/2012CN101541753B 2-aminoquinolines as 5-HT(5A) receptor antagonists
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/13/2012CN101208334B Novel cyclic amines
06/12/2012US8198483 Phenethanolamine derivatives for treatment of respiratory diseases
06/12/2012US8198458 Non-nucleoside reverse transcriptase inhibitors
06/12/2012US8198437 6-pyrimidinyl-pyrimid-4-one derivative
06/12/2012US8198313 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198307 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
06/12/2012US8198305 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent
06/12/2012US8198281 Crystalline forms of dihydropyrazolopyrimidinone
06/12/2012US8198274 Substituted indolyl and indazolyl derivatives and uses thereof
06/12/2012US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
06/12/2012US8198271 Thiophenediamine derivative having urea structure
06/12/2012US8198267 Substituted oxazolidinones and their use
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/07/2012WO2012075239A1 Serotonin reuptake inhibitors
06/07/2012WO2012074898A1 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074869A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
06/07/2012WO2012074722A1 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074719A1 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074718A1 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074703A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074135A1 Pyrimidine compound and use for pest control thereof
06/07/2012WO2012074126A1 Bicyclic compound
06/07/2012WO2012073991A1 Pyrrole derivative and process for production thereof
06/07/2012WO2012073508A1 Method for producing maleate using wet crystal
06/07/2012WO2012073506A1 Stable synthetic intermediate and method for manufacturing same
06/07/2012WO2012072791A2 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors
06/07/2012WO2012072781A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
06/07/2012WO2012072691A1 Indanyloxydihydrobenzofuranylacetic acids
06/07/2012US20120142917 Proteasome inhibitors having chymotrypsin-like activity
06/07/2012US20120142916 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
06/07/2012US20120142914 Exo-selective synthesis of himbacine analogs
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142732 Heteroaryls and uses thereof
06/07/2012US20120142714 Bicyclic compound
06/07/2012US20120142708 Substituted pyridine urea compounds
06/07/2012US20120142700 Microbiocidal heterocycles
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142690 Substituted piperidines
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142688 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications
06/07/2012US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142647 Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases
06/07/2012US20120142635 Oxazolidinone-quinolone hybrid antibiotics
06/07/2012US20120138876 Chromene compound
06/07/2012CA2832426A1 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
06/07/2012CA2819673A1 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819671A1 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819666A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819613A1 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819594A1 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819400A1 Bicyclic compound
06/07/2012CA2819389A1 5-methyl-1- (naphthalen-2-yl) -1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
06/07/2012CA2819375A1 Method for producing maleate using wet crystal
06/07/2012CA2819351A1 Stable synthetic intermediate and method for manufacturing same
06/07/2012CA2818882A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
06/06/2012EP2460804A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
06/06/2012EP2460791A1 Indole derivative and pharmacologically acceptable salt thereof
06/06/2012EP2459555A1 Processes for crystallization of rivaroxaban
06/06/2012EP2459554A2 Substituted benzamide derivatives as glucokinase (gk) activators
06/06/2012EP2459553A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
06/06/2012EP2459551A1 Dihydrobenzoindazoles
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 647